Evidence map›Paper›PMID 28980872›Full record

ArticleCell cycle (Georgetown, Tex.)2017

Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.

Ying Shi, Tong Cao, Hua Huang, Chaoqun Lian, Ying Yang, Zhiwei Wang, Jia Ma, Jun Xia

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. MicroRNA replacement therapy in cancer.Journal of cellular physiology · 2019
    Review
  17. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ying Shia Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Tong Caob Research Center of Clinical Laboratory Science , Bengbu Medical College , Bengbu , Anhui , China.
Hua Huanga Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Chaoqun Liana Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Ying Yanga Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Zhiwei Wanga Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Jia Maa Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Jun Xiaa Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.
Bengbu Medical College · CNHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arsenic trioxide (ATO) has been reported to exert its anti-cancer activities in human cancers. However, the molecular mechanism of ATO-triggered anti-tumor activity has not been fully elucidated. Recently, multiple studies demonstrated that ATO could regulate miRNAs in human cancers. Therefore, in this study, we investigated whether ATO regulated let-7a in breast cancer cells. We found that ATO upregulated let-7a level in breast cancer cells. We also found that up-regulation of let-7a inhibited cell growth and induced apoptosis and retarded cell migration and invasion. We also observed that up-regulation of let-7a enhanced cell growth inhibition and invasion suppression induced by ATO treatment. Our findings suggest that ATO suppressed cell growth, stimulated apoptosis, and retarded cell invasion partly via upregulation of let-7a in breast cancer cells. Our study provides a new anti-tumor mechanism of ATO treatment in breast cancer.

Indexed as

ApoptosisArsenic TrioxideBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationFemaleHumansMCF-7 CellsMicroRNAsNeoplasm InvasivenessUp-RegulationArsenic TrioxideMicroRNAsmirnlet7 microRNA, humanapoptosisArsenic trioxidebreast cancercell growthLet-7a

Identifiers

PMID28980872
PMCPMC5788432
OpenAlexW2761451453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.